SCHEMBL13626425

SCHEMBL13626425

Bc1ccc(B)c2nccnc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.35
MAPT P10636 2/20 0.35
CCR1 P32246 2/20 0.35
CCR5 P51681 2/20 0.35
CCR8 P51685 2/20 0.35
HSP90AA1 P07900 2/20 0.35
GMNN O75496 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
MMP2 P08253 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MMP9 P14780 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.35
MMP8 P22894 1/20 0.35
THPO P40225 1/20 0.35
MTOR P42345 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25001960 0.70 ADRA2A (0.37) KDM4EMAPTHSP90AA1LMNATP53
SCHEMBL29385656 0.69 HSP90AA1 (0.39) KDM4EMAPTCCR1CCR5CCR8
SCHEMBL29353635 0.69 HSP90AA1 (0.39) KDM4EMAPTCCR1CCR5CCR8
SCHEMBL352077 0.69 HSP90AA1 (0.39) KDM4EMAPTCCR1CCR5CCR8
SCHEMBL30358616 0.69 HSP90AA1 (0.39) KDM4EMAPTCCR1CCR5CCR8
SCHEMBL29360166 0.69 HSP90AA1 (0.39) KDM4EMAPTCCR1CCR5CCR8
SCHEMBL12599432 0.67 LMNA (0.53) KDM4EMAPTHSP90AA1LMNAMMP2
SCHEMBL15478965 0.67 HTT (0.61) KDM4EMAPTCCR1CCR5CCR8
SCHEMBL18567995 0.65 HSP90AA1 (0.41) KDM4EMAPTCCR1CCR5CCR8
SCHEMBL16533061 0.65 MAPT (0.36) KDM4EMAPTHIF1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009141386-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2009-11-26 WO disclosed